Chronic forced swim stress inhibits ultra-low dose morphine-induced hyperalgesia in rats

Behavioural Pharmacology

Volumn 18, Issue 7, 2007, Pages 667-672

  Fereidoni, Masoud ^a   Javan, Mohammad ^a   Semnanian, Saeed ^a   Ahmadiani, Abolhasan ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analgesia; Chronic stress; Hyperalgesia; Rat; Tolerance; Ultra low morphine

Indexed keywords

DEXAMETHASONE; MORPHINE; OSELTAMIVIR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENALECTOMY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HYPERALGESIA; LOW DRUG DOSE; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STRESS; SWIMMING; TAIL FLICK TEST;

ADRENALECTOMY; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; CORTICOSTERONE; DEXAMETHASONE; DRUG TOLERANCE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HYPERALGESIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAPERITONEAL; MALE; MORPHINE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 34948895536     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282f007cb     Document Type: Article

References (32)

1. Childers SR (1991). Opioid receptor coupled second messengers. Life Sci 48:1991-2003.
2. αo-dependent, μ-opioid agonist-mediated adenylyl cyclase supersensitization. J Pharmacol Exp Ther 310:215-222.
3. Crain SM, Shen KF (1996). Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem Res 21:1347-1351.
4. Crain SM, Shen KF (1998). Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 19:358-365.
5. Crain SM, Shen KF (2000). Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioids tolerance/dependence liability. Brain Res 856:227-235.
6. Crain SM, Shen KF (2001a). Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioids analgesia. Brain Res 888:75-82.
7. Crain SM, Shen KF (2001b). Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence. Brain Res 919:20-30.
8. Crain SM, Shen KF (2004). Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioids analgesia and attenuates tolerance in mice. Brain Res 995:260-266.
9. D'Amour FE, Smith DL (1941). A method of determining loss of pain sensation. J Pharmacol Exp Ther 27:74-79.
10. Esmaeili-Mahani S, Vahedi S, Motamedi F, Pourshanazari A, Khaksari M, Ahmadiani A (2005). Nifedipine potentiates antinociceptive effects of morphine in rats by decreasing hypothalamic pituitary adrenal axis activity. Pharmacol Biochem Behav 82:17-23.
11. Galeotti N, Stefano GB, Guarna M, Bianchi E, Ghelardini C (2006). Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain 123:294-305.
12. Ghiafeh-Davoodi F, Javan M, Ahmadiani A (2005). The effect of swim stress on morphine tolerance development and the possible role of nitric oxide in this process. Iranian J Pharm Res 4:167-173.
13. Garnier M, Zaratin PF, Ficalora G, Valente M, Fontanella L, Rhee MH, et al. (2003). Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine. J Pharmacol Exp Ther 304:1299-1306.
14. Ingi T, Krumins AM, Chidiac P, Brothers GM, Chung S, Snow BE, et al. (1998). Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J Neurosci 18:7178-7188.
15. Javan M, Ahmadiani A, Motamadi F, Kazemi B (2005). Changes in G proteins genes expression in rat lumbar spinal cord support the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia. Neurosci Res 53:250-256.
16. Javan M, Kazemi B, Ahmadiani M, Motamedi F (2006). Dexamethasone mimics the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia and compensates for morphine induced changes in G proteins gene expression. Brain Res 1104:73-79.
17. Melzack R (1990). The tragedy of needless pain. Sci Am 262:27-33.
18. Mogil JS, Stenberg WF, Balian H, Liebeskind JG, Sadowski B (1996). Opioid and nonopioid swim stress induced analgesia: a parametric analysis in mice. Physiol Behav 59:123-132.
19. Movahedi S, Javan M, Ahmadiani A (2006). Study on the possible similar mechanism of ultra low dose-induced hyperalgesia and development of tolerance to analgesia in male rats: a study based on the role of Gs signaling pathway. Iran Physiol Pharmacol 10:107-114.
20. Nestler EJ (2004). Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25:210-218.
21. Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, Nestler EJ (1999). Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci 19:3674-3680.
22. Powell KJ, Abul-Husn NS, Jhamandas A, Olmstead MC, Beninger RJ, Jhamandas K (2002). Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 300:588-596.
23. Quintero L, Cuesta MC, Silva JA, Arcaya JL, Pinerua-Suhaibar L, Maixner W, Suarez-Roca H (2003). Repeated swim stress increases pain-induced expression of c-Fos in the rat lumbar cord. Brain Res 965:259-268.
24. Ruscheweyh R, Sandkuhler J (2005). Opioids and central sensitisation: II. Induction and reversal of hyperalgesia. Eur J Pain 9:149-152.
25. Shen KF, Crain SM (1989). Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurous in culture. Brain Res 491:227-242.
26. Shen KF, Crain SM (1997). Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 757:176-190.
27. Solan P, Melzack R (1999). Long-term patterns of morphine; dosage and pain intensity among cancer patients. Hosp J 14:35-47.
28. Takahashi M, Kaneto H (1991). Footshock and psychological-stress prevent the development of tolerance to spinal but not supraspinal morphine. Jpn J Pharmacol 56:121-126.
29. Takahashi M, Deguchi Y, Kaneto H (1988). Blockade of the development of analgesic tolerance to morphine by concurrent treatment with opioid but not non-opioid-mediated stress in mice. Jpn J Pharmacol 46:1-5.
30. Takahashi M, Tokuyama S, Kaneto H (1992). Anti-stress effect of ginseng on the inhibition of the development of morphine tolerance in stressed mice. Jpn J Pharmacol 59:399-404.
31. Tokuyama S, Takahashi M, Kaneto H (1989). Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanism. Jpn J Pharmacol 51:425-427.
32. Williams JT, Christie MJ, Manzoni O (2001). Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-344.